Proceeds for development, commercialization of diagnostic products
By Devika Patel
Knoxville, Tenn., Oct. 8 - VentriPoint Diagnostics Ltd. said it has settled a private placement of stock. The deal priced for C$1 million on Sept. 22.
The company sold 10.7 million common shares at C$0.10 per share for C$1.07 million. The price per share is a 16.67% discount to the C$0.12 closing share price on Sept. 21.
Proceeds will be used to advance development and commercialization of the company's diagnostic products and for general corporate purposes.
Based in Calgary, Alta., VentriPoint is a clinical diagnostic company.
| Issuer: | VentriPoint Diagnostics Ltd.
|
| Issue: | Common shares
|
| Amount: | C$1.07 million
|
| Shares: | 10.7 million
|
| Price: | C$0.10
|
| Warrants: | No
|
| Pricing date: | Sept. 22
|
| Settlement date: | Oct. 8
|
| Stock symbol: | TSX Venture: VPT
|
| Stock price: | C$0.13 at close Sept. 22
|
| Market capitalization: | C$7.57 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
